Publications listed below are automatically derived from MEDLINE/PubMed and other
sources, which might result in incorrect or missing publications. Faculty can
to make corrections and additions.
Showing 10 of 25 results.
Balser J, Chang M, Bliss R. Interpreting the Regulatory Perspective on Adaptive Designs. Statistics in Biopharmaceutical Research. 2018.
Quan H, Mao X, Tanaka Y, Chang M. Example-based illustrations of design, conduct, analysis and result interpretation of multi-regional clinical trials. Contemporary clinical trials. 2017.
Teng Z, Chen YF, Chang M. Unified additional requirement in consideration of regional approval for multiregional clinical trials. J Biopharm Stat. 2017; 27(6):903-917. PMID: 28287339
Ravathi A, Green S, Chang M, Lavalley MP. Systematic comparison of the statistical operating characteristics of various Phase I oncology designs. 2016.
Chang M. What Constitutes Science and Scientific Evidence. Educational and Psychological Measurement. 2016; 77(3).
Teng Z, Chang M. Multiregional Clinical Trials for Simultaneous Global New Drug Development, Editors: Joshua Chen, Hui Quan. Optimal Multiregional Clinical Trials. 2016; (10):113-128.
Teng Z, Chang M. Multiregional Clinical Trials for Simultaneous Global New Drug Development. Adaptive Multiregional Clinical Trials. 2016; 177-191.
Chang M, Deng X, Balser J. An Alpha-Exhaustive Multiple Testing Procedure. Current Research in Biostatistics. 2016; (6):30-41.
Chang M, Wang J. Trial Design and Analysis with Incomplete Paired Data
. American Journal of Biostatistics
. 2015; 6.
This graph shows the total number of publications by year, by first, middle/unknown,
or last author.